TCL Archive FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials January 27, 2012
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive PDQ Used Mainly For Information To Public, Not Much By Non-Oncologists, Evaluation Finds August 18, 1989
